G I Barbash
Sheba Medical Center
22 Papers
304 Citations
G I Barbash is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Myocardial infarction & Infarction. The author has an hindex of 12, co-authored 22 publications.
Chat about Author
Papers
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
G I Barbash,Harvey D. White,Michaela Modan,Rafael Diaz,John R. Hampton,Juhani Heikkilä,A Kristinsson,S Moulopoulos,E A Paolasso,T. van der Werf +9 more
TL;DR: It is indicated that smokers receiving thrombolytic therapy after acute myocardial infarction have significantly better hospital and 6-month outcome than nonsmokers or ex-smokers and strenuous efforts should be made to decrease the incidence of new and continued smoking.
208
After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study.
Harvey D. White,G I Barbash,Michaela Modan,John Simes,Rafael Diaz,John R. Hampton,Juhani Heikkilä,A Kristinsson,S Moulopoulos,E A Paolasso +9 more
TL;DR: After thrombolytic therapy for acute myocardial infarction, women have similar morbidity and mortality to men but suffer from a higher incidence of hemorrhagic stroke.
175
Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents. A comparison of TNK-tPA and rt-PA
F. Van de Werf,Hal V. Barron,Paul W. Armstrong,Christopher B. Granger,S Berioli,G I Barbash,Kenneth Pehrsson,F.W. Verheugt,Jürgen Meyer,Amadeo Betriu,Robert M. Califf,Xuri Li,NL Fox +12 more
TL;DR: The increased fibrin specificity and single bolus administration of TNK-tPA do not increase the risk of intracranial haemorrhage but are associated with less non-cerebral bleeding, especially amongst high-risk patients.
Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction.
G I Barbash,Arie Roth,H Hod,Hylton I. Miller,S Rath,Y Har-Zahav,M Modan,U Seligsohn,Alexander Battler,Elieser Kaplinsky +9 more
TL;DR: Rapid resolution of ST elevations in patients undergoing thrombolysis with alteplase was associated with a significantly smaller release of creatine kinase, better preservation of left ventricular function, lower morbidity, and less short and long term mortality.
98
Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
TL;DR: Antecedent angina predicts a worse clinical outcome and a more intense use of medical resources in patients with acute myocardial infarction receiving thrombolytic therapy with either recombinant tissue-type plasminogen activator or streptokinase.
75